Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Anticancer Research|July 26, 2024
Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell LymphomaRiina K Ollikainen, Antti Sippola, Taina Turpeenniemi-Hujanen, et al.
Leukemia & Lymphoma|April 15, 2021
Different chemokine profile between systemic and testicular diffuse large B-cell lymphomaRiina K Ollikainen, Pyry H Kotkaranta, Janette Kemppainen, et al.
European Journal of Haematology|January 9, 2025
Favourable Outcome of Relapsed PCNSL Among Transplant Eligble PatientsEetu Pellonperä, Inka Puhakka, Hanne Kuitunen, et al.
Human Pathology|August 8, 2021
Incidence and clinicopathological features of Follicular T-cell lymphoma in Finland: a population-based immunohistochemical studyJenni Kiiskilä, Pyry Uotila, Kirsi-Maria Haapasaari, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2024
Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practiceAino Rajamaki, Marc Sorigue, Roosa E I Prusila, et al.
Cancers|March 11, 2023
The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF CasesMarjaana J Häyrinen, Jenni Kiiskilä, Annamari Ranki, et al.
Cancers|January 11, 2025
Correction: Häyrinen et al. The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases. <i>Cancers</i> 2023, <i>15</i>, 1527Marjaana J Häyrinen, Jenni Kiiskilä, Annamari Ranki, et al.
JCO Clinical Cancer Informatics|September 27, 2023
Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter DataAino Rajamäki, Mika Hujo, Reijo Sund, et al.
Cancer|April 13, 2022
Mortality among patients with low-grade follicular lymphoma: A binational retrospective analysisAino Rajamäki, Mika Hujo, Reijo Sund, et al.
Oxidative Medicine and Cellular Longevity|February 19, 2021
Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease PresentationMikko C Chan, Janette Savela, Riina K Ollikainen, et al.
Pageof 3